General Information of the Compound
Compound ID |
CP0008374
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
1-(bis(4-fluorophenyl)methyl)-4-cinnamylpiperazine
Show/Hide
|
||||||||||||||||||
Synonyms |
(E)-1-(Bis(4-fluorophenyl)methyl)-4-(3-phenyl-2-propenyl)piperazine
(E)-1-[Bis-(p-fluorophenyl)methyl]-4-cinnamylpiperazine
1-(Bis(4-fluorophenyl)methyl)-4-cinnamylpiperazine
1-[bis(4-fluorophenyl)methyl]-4-(3-phenylprop-2-en-1-yl)piperazine
1-[bis(4-fluorophenyl)methyl]-4-[(E)-3-phenylprop-2-enyl]piperazine
Apo-flunarizine capsules
Flufenal
Flunarizin
Flunarizina
Flunarizina [INN-Spanish]
Flunarizine
Flunarizine (INN)
Flunarizine [INN:BAN]
Flunarizinum
Flunarizinum [INN-Latin]
Fluvert
Issium
Novo-Flunarizine
R-14950
Sibelium
Sibelium (TN)
Vertix
Zinasen
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C26H26F2N2
|
||||||||||||||||||
Molecular Weight |
404.504
|
||||||||||||||||||
Canonical SMILES |
Fc1ccc(cc1)C(N1CCN(C\C=C\c2ccccc2)CC1)c1ccc(F)cc1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C26H26F2N2/c27-24-12-8-22(9-13-24)26(23-10-14-25(28)15-11-23)30-19-17-29(18-20-30)16-4-7-21-5-2-1-3-6-21/h1-15,26H,16-20H2/b7-4+
Show/Hide
|
||||||||||||||||||
InChIKey |
SMANXXCATUTDDT-QPJJXVBHSA-N
|
||||||||||||||||||
CAS |
40218-96-0
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT04059, Sodium channel protein type 2 subunit alpha
Protein ID: PT02031, Voltage-dependent N-type calcium channel subunit alpha-1B
Clinical Information about the Compound